Lexaria Bioscience Corp. (LEXXW)

Lexaria Bioscience Corp. is a biotechnology company focused on improving the way active pharmaceutical ingredients (APIs) enter the bloodstream, thereby enhancing their effectiveness. The company's patented DehydraTECH™ technology is designed to increase the bioavailability of APIs, potentially leading to faster onset of action and improved therapeutic outcomes. Lexaria's research and development efforts span various therapeutic areas, including hypertension, diabetes, and neurological disorders. By optimizing drug delivery, Lexaria aims to create more effective and patient-friendly treatments, contributing to advancements in the pharmaceutical and healthcare sectors. The company is actively engaged in pre-clinical and clinical studies to validate the benefits of its DehydraTECH™ platform across a range of applications, seeking to partner with pharmaceutical companies to integrate its technology into existing and novel drug formulations.